The proportion of CD14 + CD16 + monocytes from COPD patients expressing CCR5 was significantly greater than S (medians 14.3% versus 4.9%; p < 0.05) but did not reach statistical significance compared to HNS (median 2.7%, p = 0.09).
1
0.0900
0.0900
The proportion of CD14 + CD16 + monocytes from COPD patients expressing CCR5 was significantly greater than S (medians 14.3% versus 4.9%; p < 0.05) but did not reach statistical significance compared to HNS (median 2.7%, p = 0.09).